Clinical Trials in Dallas

Showing 10301-10320 of 17,468 trials

A Study of LY3556050 in Healthy Participants

NCT04156750

The main purpose of this study is to learn more about the safety of LY3556050 after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3556050 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3556050 or placebo and will remain in the study for up to 31 days.

Healthy

Eli Lilly and Company34 participantsStarted Nov 2019

Dallas, Texas, United States

COMPLETEDPhase 3< 1 mile

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

NCT00006400

The purpose of this study is to determine if hydroxyurea therapy is effective in the prevention of chronic end organ damage in pediatric patients with sickle cell anemia.

Hematologic DiseasesAnemia, Sickle Cell

National Heart, Lung, and Blood Institute (NHLBI)193 participantsStarted Aug 2000

Birmingham, Alabama, United States • Washington D.C., District of Columbia, United States • Washington D.C., District of Columbia, United States +11 more locations

A Study of LY3556050 in Healthy Participants

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

Find Trials by Condition in Dallas

Sexual Function Trial of Overactive Bladder: Medication Versus PTNS

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Non-contrast 3-dimensional Cardiac Magnetic Resonance Imaging

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Electrical Activation of The Diaphragm for Ventilatory Assist

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

A Safety Study of NNZ-2566 in Pediatric Rett Syndrome

Prospective Multicenter Trial to Compare Preformed vs Non Preformed Orbital Implants

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease